chitosan has been researched along with puerarin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Changqing, Y; Weiping, S; Xiangzheng, K; Yanjing, C; Zhiguo, Z | 1 |
Ling, PX; Lü, QZ; Wang, HG; Zhai, GX | 1 |
Dai, W; Han, M; Kang, R; Liao, D; Liu, X; Ou, G; Tang, T; Xiang, D; Yang, S; Zhang, K | 1 |
Cui, YL; Gao, LN; Hou, JY; Meng, FY | 1 |
Gao, JQ; Liu, L; Lou, Y; Lu, XY; Miao, J; Wu, JY; Yang, H | 1 |
5 other study(ies) available for chitosan and puerarin
Article | Year |
---|---|
Self-assembly of an amphiphilic derivative of chitosan and micellar solubilization of puerarin.
Topics: 2-Propanol; Buffers; Caustics; Chitosan; Dialysis; Drug Carriers; Isoflavones; Light; Micelles; Microscopy, Electron; Molecular Weight; Particle Size; Polymers; Scattering, Radiation; Sodium Hydroxide; Solubility; Solvents; Spectrometry, Fluorescence; Temperature; Viscosity; Water | 2006 |
[Preparation and characterization of chitosan coated puerarin liposomes].
Topics: Chitosan; Drug Carriers; Drug Stability; Fabaceae; Isoflavones; Liposomes; Particle Size; Plants, Medicinal; Technology, Pharmaceutical | 2007 |
N-trimethyl chitosan (TMC)-modified microemulsions for improved oral bioavailability of puerarin: preparation and evaluation.
Topics: Administration, Oral; Animals; Biological Availability; Chitosan; Drug Carriers; Emulsions; Isoflavones; Male; Particle Size; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 2015 |
Mucoadhesive microparticles for gastroretentive delivery: preparation, biodistribution and targeting evaluation.
Topics: Adhesiveness; Alginates; Animals; Chitosan; Dinoprostone; Drug Delivery Systems; Gastric Mucosa; Gelatin; Glucuronic Acid; Hexuronic Acids; Inflammation; Interleukin-1beta; Interleukin-6; Isoflavones; Male; Microspheres; Particle Size; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Tissue Distribution; Tumor Necrosis Factor-alpha | 2014 |
Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles.
Topics: Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Calcitonin; Cell Survival; Chitosan; Drug Carriers; Drug Liberation; Humans; Intestinal Absorption; Intestinal Secretions; Isoflavones; Nanoparticles; Rats, Sprague-Dawley | 2019 |